CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0330
-0.0006 (-1.67%)
Sep 8, 2025, 3:39 PM EDT
CV Sciences Employees
As of December 31, 2024, CV Sciences had 49 total employees, including 47 full-time and 2 part-time employees. The number of employees increased by 6 or 13.95% compared to the previous year.
Employees
49
Change (1Y)
6
Growth (1Y)
13.95%
Revenue / Employee
$311,979
Profits / Employee
-$32,333
Market Cap
6.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49 | 6 | 13.95% |
Dec 31, 2023 | 43 | -1 | -2.27% |
Dec 31, 2022 | 44 | -27 | -38.03% |
Dec 31, 2021 | 71 | -25 | -26.04% |
Dec 31, 2020 | 96 | -29 | -23.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
HealthLynked | 20 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
CV Sciences News
- 13 days ago - CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & ... - GuruFocus
- 13 days ago - CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus - Accesswire
- 19 days ago - CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - CV Sciences Non-GAAP EPS of $0.00, revenue of $3.62M - Seeking Alpha
- 26 days ago - CV Sciences Sales Down 10 Percent - The Motley Fool
- 26 days ago - CV Sciences, Inc. Reports Second Quarter 2025 Financial Results - Accesswire
- 4 weeks ago - CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025 - Accesswire
- 2 months ago - Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025 - Benzinga